Bridgeway Capital Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $21.5K | Hold |
|
|||||
|
2023
Q1 | $28.3K | Sell |
|
|||||
|
2022
Q4 | $61.4K | Hold |
|
|||||
|
2022
Q3 | $85K | Sell |
|
|||||
|
2022
Q2 | $189K | Sell |
|
|||||
|
2022
Q1 | $361K | Sell |
|
|||||
|
2021
Q4 | $569K | Sell |
|
|||||
|
2021
Q3 | $1.05M | Buy |
|
|||||
|
2021
Q2 | $791K | Buy |
|
|||||
|
2021
Q1 | $639K | Hold |
|
|||||
|
2020
Q4 | $453K | Buy |
|
|||||
|
2020
Q3 | $341K | Sell |
|
|||||
|
2020
Q2 | $402K | Buy |
|
|||||
|
2020
Q1 | $167K | Sell |
|
|||||
|
2019
Q4 | $566K | Buy |
|
|||||
|
2019
Q3 | $609K | Hold |
|
|||||
|
2019
Q2 | $1.09M | Hold |
|
|||||
|
2019
Q1 | $436K | Buy |
|
|||||
|
2018
Q4 | $165K | Hold |
|
|||||
|
2018
Q3 | $453K | Hold |
|
|||||
|
2018
Q2 | $541K | Buy |
|
|||||
|
2018
Q1 | $426K | Hold |
|
|||||
|
2017
Q4 | $613K | Hold |
|
|||||
|
2017
Q3 | $410K | Hold |
|
|||||
|
2017
Q2 | $832K | Hold |
|
|||||
|
2017
Q1 | $985K | Sell |
|
|||||
|
2016
Q4 | $904K | Hold |
|
|||||
|
2016
Q3 | $757K | Buy |
|